Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
2
22%
Ph not_applicable
7
78%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
2(22.2%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(3)
Terminated(1)
Other(5)

Detailed Status

unknown5
Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (22.2%)
N/A7 (77.8%)

Trials by Status

terminated111%
unknown556%
completed333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9